Related Experiment Video
Updated: Jun 20, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Anatomical features of percutaneously closed patent foramen ovale in patients with cryptogenic stroke
Maikel H M Immens1, Lars S Witte2, Abdelhak El Bouziani2
1Department of Neurology, Radboudumc, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
Background:
Patent foramen ovale (PFO) is increasingly recognized as a cause of stroke, with a prevalence of approximately 25% in the general population. Consequently, the likelihood of encountering a 'bystander PFO' in young patients who have experienced a stroke seems significant. To aid in identifying patients with a PFO-related cryptogenic stroke, an interdisciplinary Heart-Stroke Team (HST) has been established. This team evaluates patients who have suffered from stroke and were diagnosed with a PFO to assess its potential contribution. Understanding the anatomical features of PFOs associated with stroke is essential for decision-making. This study examines the PFO characteristics of all patients who underwent percutaneous PFO closure for cryptogenic stroke at two congenital heart disease institutions in the Netherlands.
Methods:
Data on all patients who underwent PFO closure from 2016 to 2022 were collected. Anatomical characteristics were measured using transesophageal echocardiography and analyzed by two cardiologists.
Results:
In total, 223 patients underwent PFO closure. The mean age was 42.8 ± 10.7 years, with 115 (51.6%) being male. Approximately 80% of all patients had at least one risk-enhancing PFO feature (moderate to severe shunt and/or atrial septal aneurysm of > 10 mm).
Conclusion:
Although all patients accepted for percutaneous PFO closure were individually assessed by a dedicated HST, 20% had a PFO without risk-enhancing features but were still accepted for closure due to other reasons. This highlights the importance of careful individual assessment of young stroke patients with a PFO. Future studies are needed to identify the characteristics that contribute to stroke in these patients.
Insights
Patent foramen ovale (PFO) closure is common for cryptogenic stroke, but 20% of patients lacked typical risk factors. Individual assessment by a Heart-Stroke Team is crucial for PFO-related stroke management.
Area of Science:
- Cardiology
- Neurology
- Medical Diagnostics
Background:
- Patent foramen ovale (PFO) is a common condition, found in ~25% of the general population.
- PFO is increasingly recognized as a cause of cryptogenic stroke, particularly in younger individuals.
- Identifying PFO as the cause of stroke is crucial for appropriate patient management.
Purpose of the Study:
- To examine the anatomical characteristics of PFOs in patients who underwent percutaneous PFO closure for cryptogenic stroke.
- To assess the prevalence of risk-enhancing PFO features in patients undergoing closure.
- To evaluate the role of interdisciplinary Heart-Stroke Teams (HST) in patient selection.
Main Methods:
- Retrospective data collection of patients undergoing PFO closure between 2016 and 2022.
- Transesophageal echocardiography was used to measure PFO anatomical characteristics.
- Analysis performed by two experienced cardiologists.
Main Results:
- 223 patients underwent PFO closure, with a mean age of 42.8 years.
- Over 80% of patients exhibited at least one risk-enhancing PFO feature (moderate-to-severe shunt and/or atrial septal aneurysm >10 mm).
- Despite HST assessment, 20% of closed PFOs lacked these specific risk-enhancing features.
Conclusions:
- Individualized assessment by a Heart-Stroke Team is vital for managing young stroke patients with PFO.
- A significant proportion of patients undergoing PFO closure may not present with all typical risk-enhancing features.
- Further research is needed to elucidate stroke mechanisms in PFO patients without clear risk factors.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology

